Reply: Olanzapine Versus Quetiapine: Corrected QT Changes in Critically Ill Patients

Abstract

Get full access to this article

View all access options for this article.

References

Stroup

Lieberman

McEvoy

, et al. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. Am J Psychiatry. 2006;163(4):611-622. doi:10.1176/ajp.2006.163.4.611

Lieberman

Stroup

McEvoy

, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia [published correction appears in N Engl J Med. 2010 Sep 9;363(11):1092-3]. N Engl J Med. 2005;353(12):1209-1223. doi:10.1056/NEJMoa051688

Huhn

Nikolakopoulou

Schneider-Thoma

, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939-951. https://doi.org/10.1016/S0140-6736(19)31135-3

Dube

DeGrado

Hohlfelder

Szumita

PM.

Evaluation of the effects of quetiapine on QTc prolongation in critically ill patients. J Pharm Pract. 2018;31(3):292-297. doi:10.1177/0897190017711875

Hanna

Adie

Ketcham

, et al. Atypical antipsychotic safety in the CICU. Am J Cardiol. 2022;163:117-123. doi:10.1016/j.amjcard.2021.09.052

U.S. Food & Drug Administration. E14 and S7B clinical and nonclinical evaluation of QT/QTc interval prolongation and proarrhythmic potential—questions and answers: guidance for industry. Published August 2022. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e14-and-s7b-clinical-and-nonclinical-evaluation-qtqtc-interval-prolongation-and-proarrhythmic

Stollings

Boncyk

Birdrow

, et al. Antipsychotics and the QTc interval during delirium in the intensive care unit: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2024;7(1):e2352034. doi:10.1001/jamanetworkopen.2023.52034

Wang

Yankama

Abdallah

, et al. A retrospective comparison of the effectiveness and safety of intravenous Olanzapine versus intravenous haloperidol for agitation in adult intensive care unit patients. J Intensive Care Med. 2022;37(2):222-230. doi:10.1177/0885066620984450